shown in Moleculin's European clinical study for the treatment of AML using Annamycin in combination with Cytarabine (MB-106) a preliminary 60% composite complete response (CRc) rate in 2nd line subjects (N=10) and an overall interim CRc of 39% in...
Coulter's validated HBsAg High Positive algorithm eliminates the need for repeat and confirmatory testing for samples ≥ 100.00 S/CO with 96.9% of initially reactive samples being able to be directly reported as positive providing laboratories with...
efficacy in the treatment of erectile dysfunction. These drugs have an excellent safety profile with experience in over 1,600 patients in clinical studies to date. For more information please visit: www.canfite.com.
in adults with type 2 diabetes. BRENZAVVY is not recommended for use to improve glycemic control in patients with type 1 diabetes mellitus. The randomized, double-blind, active-controlled trial enrolled 406 patients with type 2 diabetes mellitus at...
Algiax Pharmaceuticals, today provided an update on its ongoing Phase 2a study (NCT04429919) with lead candidate AP-325 in patients with chronic neuropathic pain. Based on last year's positive mid-enrollment interim analysis and confirmed...
Inc. reports early efficacy results showing tumor stabilization in the third patient enrolled in the Company’s Deltacel-01 Phase 1 clinical trial. Deltacel-01 is evaluating Deltacel™ (KB-GDT-01), Kiromic’s allogeneic. off-the-shelf, Gamma Delta...
a nurse educator, reimbursement support, and a clinical pharmacist. For more information, visit PyrosTotalCare.com or call 1-888-760-8330, Monday to Friday, 8 a.m. to 5 p.m. Central Time. About Infantile Spasms: Infantile spasms (IS) is a rare,...
by its poor absorption. Berberine Enhanced Absorption solves this problem with berberine phytosome™, which boasts up to 10 times greater bioavailability compared to standard berberine.* Theralogix raises the bar when it comes to premium,...
Upsher-Smith Laboratories, LLC (Upsher-Smith) announced the recent launch of Methimazole Tablets, USP, 5 mg and 10 mg. The Methimazole Tablet market had U.S. sales of approximately $36.8 million for the 12 months ending December 2023 according to...
already activated, we look forward to dosing the first patients in this trial in the first half of this year." The Phase 1 open-label, single-arm, two-part study (NCT06326411) is intended to investigate the safety, pharmacokinetics (PK),...
Neurocrine Biosciences, Inc. announced the initiation of its Phase 1 clinical study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of investigational compound NBI-1065890 in healthy adult participants. NBI-1065890 is...
of a new study in the prestigious peer-reviewed journal American Journal of Respiratory and Critical Care Medicine (AJRCCM)1, resulting from a research collaboration AstraZeneca, the UK's leading Biopharmaceutical company. The results showed that...
in August 2020. Results from the INNO2VATE program were published in the New England Journal of Medicine: (N Engl J Med 2021; 384:1601-1612); (N Engl J Med 2021; 384:1589-1600). See the Important Safety Information section below, including BOXED...
and other medical devices, recently received Emergency Use Authorization (EUA) for its CorDx Tyfast Flu A/B & COVID-19 Multiplex Rapid Test. The 3-in-1 multiplex test is a lateral flow immunoassay device intended for the qualitative detection and...
critical neurochemicals involved in cognitive function, healthy memory, and long-term mental fitness; and Vitamins B6 and B12, two brain vitamins that support brain energy production, neurotransmitter synthesis, and homocysteine detoxification....
successful global Phase III ZIRCON study (Zirconium in Renal Cancer Oncology, ClinicalTrials.gov Identifier: NCT03849118), which reported positive results in November 2022, meeting all co-primary and secondary endpoints.[2] Arturo Chiti, Professor...
pharmaceutical, biotechnology, medical device, and CRO companies to streamline product development lifecycles in a secure, 21 CFR Part 11-compliant environment. By offering a fully integrated, AI-enhanced user experience, Trial Interactive improves...
Aptamer Sciences Inc. (KOSDAQ, 291650) announced the filing of an Investigational New Drug (IND) application for the phase 1 clinical trial of AST-201. AST-201, the company's pioneering candidate in its pipeline, is an ApDCTM (Aptamer-Drug...
locations, glaucoma staging using Medicare definitions, and an exceptionally high correlation of 0.94 in mean deviation.1 These results underscore the unparalleled accuracy and reliability of RadiusXR's approach to visual field testing for...
– Night Use features include: Fast-Acting: The patented Fusionner technology promises swift relief, with an onset of just 15 minutes. Enhanced Absorption: With a 50% surge in bioavailability, the technology optimizes the body's absorption rates....
